Melitracen Completed Phase 4 Trials for Tinnitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00841230Deanxit and Rivotril in Tinnitus Patients